TACTILE SYSTEMS TECHNOLOGY INC Key Metrics

3 years of history · ending 2025-12-31 · SEC EDGAR

Forensics

Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.

F-Score (Piotroski 0-9)

Z-Score (Altman; <1.81 = distress)

Per Share Metrics

Turnover & Efficiency Analysis (days)

Expense Ratios

Working Capital Analysis

Valuation Multiples

Cash-Flow Multiples

Enterprise Value Multiples

52-Week Range

Trailing Returns

ROIC vs WACC

Yields

Capital Deployment Yields

Liquidity & Leverage Ratios

Earnings Quality (OCF/NI · FCF/NI · Sloan Accruals)

EPS (Diluted)
$1
Book Value Per Share
$9
Free Cash Flow Per Share
$2
Cash Per Share
$4
Revenue Per Share
$14
OCF Per Share
$2
Return on Equity
8.8%
Return on Assets
6.7%
Return on Invested Capital
8.2%
Debt to Equity
0.00
Current Ratio
4.03
Quick Ratio
3.69
Asset Turnover
1.15
Days Sales Outstanding
48.60
Days Payables Outstanding
22.84
Days Inventory On Hand
64.49
Cash Conversion Cycle
90.25
R&D / Revenue
2.6%
SBC / Revenue
2.5%
Capex / Revenue
0.7%
Working Capital
$124M
Net Current Asset Value
$110M
Invested Capital
$219M
OCF / Net Income
2.24
FCF / Net Income
2.12
Accruals Ratio (Sloan)
-8.7%
Net Debt
$-83M
Net Debt / EBITDA
-2.32
Interest Coverage
28.21
Cash Coverage
41.24
Capex Coverage
17.99
Tangible Common Equity
$149M
TCE / Total Assets
54.3%
Goodwill / Total Assets
11.3%
NOPAT
$18M
Cash ROIC
18.6%
WC / Revenue
37.7%
Capex / D&A
0.36
Reinvestment Rate
-14.6%
Total Payout Ratio
139.2%
Asset Growth vs Revenue Growth
-20.5%
Revenue 5Y CAGR
12.0%
EPS 5Y CAGR
9.1%
FCF 5Y CAGR
122.9%
EBITDA 5Y CAGR
15.6%
Book Value 5Y CAGR
11.9%
Stock Price (FY-end)
$29
Market Cap
$676M
P/E Ratio
35.40
P/S Ratio
2.05
P/B Ratio
3.09
P/TB Ratio
4.54
P/OCF Ratio
15.78
P/FCF Ratio
16.71
Enterprise Value
$592M
EV / EBITDA
16.48
EV / Sales
1.80
EV / FCF
14.65
FCF Yield
6.0%
Shareholder Yield
2.7%
Buyback Yield
3.9%
R&D Yield
1.3%
Capex Yield
0.4%
Operating Leverage
2.57
Graham Number
$13
Shares Variation (YoY)
-3.5%
Beta (5Y)
1.06
Cost of Equity
9.8%
52W High
$30
52W Low
$9
Trailing Return 1Y
68.1%
Trailing Return 5Y
-31.8%
F-Score (Piotroski)
7.00
Z-Score (Altman)
9.74

Earnings Forecasts

Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).

Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.

EPS — Consensus vs Actual

Revenue — Consensus vs Actual

Beat / Miss vs Estimate

Stock Price on Earnings Dates

TACTILE SYSTEMS TECHNOLOGY INC — Effective Tax Rate ReconciliationNEW

Bridges from the federal statutory rate (21% post-TCJA) to the effective tax rate via the issuer's tax-note reconciliation lines. Sourced from EffectiveIncomeTaxRateReconciliation* flat CompanyFacts concepts. Conditional lines (R&D credits, FDII, SBC, valuation allowance, etc.) only render when the issuer discloses them. Persistent divergence between accrual tax expense and cash taxes paid is a leading signal for deferred-tax buildup.

Effective Rate Trend

Reconciliation LineFY2020FY2021FY2022FY2023FY2024FY2025
Federal Statutory Rate21.00%21.00%21.00%21.00%21.00%21.00%
State & Local Income Taxes-7.90%-1.10%4.10%-23.93%5.66%6.97%
Foreign Rate Differential
Other Adjustments-0.20%-0.50%-0.50%3.03%0.03%0.20%
R&D Tax Credits1.55%1.49%0.85%
Valuation Allowance Change8.00%-5.25%-37.40%-84.04%
Tax Settlements (Domestic)
Effective Tax Rate72.60%-4.15%-15.50%-81.01%27.79%39.10%

Cash vs Accrual

ItemFY2020FY2021FY2022FY2023FY2024FY2025
Income Tax Expense (Accrual)−$1.6M$9.5M$2.4M−$12.7M$6.5M$12.3M
Income Taxes Paid (Cash)$7.4M$6.9M$2.5M

TACTILE SYSTEMS TECHNOLOGY INC — M&A AcquisitionsNEW

Per-deal acquisition disclosures sourced from us-gaap:BusinessAcquisitionAxis dimensional XBRL. Each card surfaces the deal's purchase-price allocation (goodwill vs intangibles vs liabilities), contingent consideration (unpaid earn-outs), and pro-forma combined-entity numbers. Probability-of-Success (PoS) factor on biotech targets is the ASC 805 contingent-consideration valuation — higher = closer to commercialization, higher implied target value.

Afflovest P

Purchase-Price Allocation

Goodwill

$31.1M